UC Davis Cancer Center News
Synthesis
Angela Echeverri-Lompre and eight other UC Davis students are at the forefront of medicine through the cancer center's Emerging Technologies Continuing Umbrella Research Experiences program (ET-CURE).
Arginine deiminase, a novel drug for cancer, is like a saw to a carpenter who has had only a hammer, says Rick Bold, UC Davis chief of surgical oncology.
Imaging techniques that use ionizing radiation have had a tremendous impact on cancer care. Radiation therapy, in which tumors are targeted with higher doses of radiation, has saved the lives of countless cancer patients.
As soon as she was diagnosed in January 2009, Shadowens, 42, was determined to get the treatment she both needed and wanted. She found herself in the care of Dr. Steve Martinez, a surgical oncologist at UC Davis Cancer Center.
The idea seemed irresistible to Holly Degner at the time, a surefire ticket to teen coolness - a tattoo.
At UC Davis Cancer Center, we have dedicated ourselves to understanding cancer on multiple levels, from its most intricate molecular characteristics to the physical, emotional and social impact it has on people's lives. This deep and far-reaching approach to the disease is especially important because we know that cancer affects different people in different ways. Read more
The online version of
Synthesis magazine, a
publication of UC Davis
Health System, is
sporting a new look.
Take a few minutes to
check out the
new features.
Finding funds to support pioneering laboratory work is almost as arduous as the science itself. That's what makes the support of the Auburn Community Cancer Endowment Fund so vital to the UC Davis Cancer Center.
The endowment fund got its start in 2001 after three friends in the Sierra foothills city got together over a cup of coffee and decided to raise money for the war on cancer. Read more
